文献速递临床试验与 GCP

黄龙神奇种子方治疗痛风湿热下注证高尿酸血症的初步随机对照试验

"Yellow-dragon Wonderful-seed Formula" for hyperuricemia in gout patients with dampness-heat pouring downward pattern: a pilot randomized controlled trial.
PubMed 文献 · Trials · 2018-10-11

该初步随机对照试验纳入72例痛风伴湿热下注证高尿酸血症患者,62例完成试验,随机分为黄龙神奇种子方组、黄龙神奇种子方加石膏组和别嘌醇组,口服给药四周。结果显示黄龙神奇种子方未显著降低血尿酸水平,但别嘌醇及两中药组均降低尿尿酸水平,且黄龙神奇种子方组与加石膏组间差异显著。

要点

  • 黄龙神奇种子方未显著降低痛风湿热下注证患者的血尿酸水平。
  • 黄龙神奇种子方和加石膏方均降低尿尿酸水平,组间有显著差异。
  • 别嘌醇作为阳性对照同样降低尿尿酸水平,三组间CRP和SF-36无显著差异。

核心结论

  • 黄龙神奇种子方未显示出显著的降血尿酸效应。
  • 石膏可能为黄龙神奇种子方降低尿尿酸水平提供额外效应,但其他结局未获益。

研究设计与样本

  • 初步随机对照试验,纳入72例痛风伴湿热下注证高尿酸血症患者,62例完成试验。
  • 参与者随机分为黄龙神奇种子方组、黄龙神奇种子方加石膏组和别嘌醇组,口服给药四周。

主要发现

  • 与第0周相比,黄龙神奇种子方和加石膏方在各周末均未显著降低血尿酸水平。
  • 黄龙神奇种子方、加石膏方和别嘌醇均降低尿尿酸水平,黄龙神奇种子方组与加石膏组间有显著差异。
  • 干预期间SF-36八个维度的变化三组间均无显著差异,各周末CRP水平三组间亦无显著差异。

临床怎么用

  • 对于痛风湿热下注证患者,黄龙神奇种子方不宜作为降血尿酸的主要治疗选择。
  • 石膏可能增强黄龙神奇种子方降低尿尿酸的作用,但需进一步验证。

局限性

  • 为初步试验,样本量有限,完成试验仅62例。
  • 干预周期较短,仅四周。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Traditional Chinese Medicine (TCM) theories, the typical clinical manifestations of gout are attributed to the "dampness-heat pouring downward." Therefore, TCM practitioners always consider prescribing the formulae which are believed to clear heat and drain dampness for the management of gout. This clinical trial aims: (1) to determine the hypouricemic effect of "Yellow-dragon Wonderful-seed Formula" (YWF) decoction in gout patients with dampness-heat pouring downward pattern and (2) to determine if gypsum could provide additional significant benefits to YWF. METHODS: A total of 72 hyperuricemic individuals with gout and dampness-heat pouring downward pattern were included with 62 of them completing the trial. Participants were randomly assigned to the YWF group, the YWF + gypsum group, or the allopurinol group. YWF and YWF + gypsum decoctions were orally administered for four weeks. Allopurinol was also orally administered for four weeks as the active control. Serum uric acid (sUA) level was the primary outcome measure. Urine urate level, scores on the SF-36 scale, erythrocyte sedimentation rate (ESR), X ray film, and C reactive protein (CRP) level were the secondary outcome measures. RESULTS: Compared with the values at week 0, YWF and YWF + gypsum did not significantly decrease the sUA level at each weekend reading. YWF, YWF + gypsum, and allopurinol decreased the urine urate levels and there were significant differences between the YWF group and the YWF + gypsum group. All the changes in the eight structures of SF-36 during the intervention period were not significantly different among the three groups and there was no significant difference in the CRP level among the three groups at each weekend reading. CONCLUSIONS: YWM, which modified on the basis of Two Wonderful Herbs Powder (2WHP), does not show significant hypouricemic effect. There is a possibility that Gypsum Fibrosum may provide additional effects to YWF in decreasing the urine urate levels but cannot add benefits to YWF in other outcome measures. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-TRC-12001933 . Registered on 10 February 2012.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yu XN, Wu HY, Deng YP, et al. "Yellow-dragon Wonderful-seed Formula" for hyperuricemia in gout patients with dampness-heat pouring downward pattern: a pilot randomized controlled trial. Trials. 2018. PMID: 30314508. doi:10.1186/s13063-018-2917-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。